Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitis.
Fiche publication
Date publication
juillet 2023
Journal
Journal of gastroenterology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Parkes G, Ungaro RC, Danese S, Abreu MT, Arenson E, Zhou W, Ilo D, Laroux FS, Deng H, Sanchez Gonzalez Y, Peyrin-Biroulet L
Lien Pubmed
Résumé
We evaluated the clinical relevance of achieving histologic endoscopic mucosal improvement (HEMI) and the more stringent target of histologic endoscopic mucosal remission (HEMR) in the phase 3 maintenance trial of upadacitinib for moderately to severely active ulcerative colitis.
Mots clés
Histologic endoscopic mucosal improvement, Histologic endoscopic mucosal remission, Inflammatory bowel disease
Référence
J Gastroenterol. 2023 07 25;: